SUZANNE NIEMAN: Open Payments
NPI 1891907580 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 5 payments from 5 companies in 2025. Trend: 2023 $17 · 2024 $0 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| ABBVIE INC. | 1 | $98 |
| Neuronetics, Inc. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: FANAPT, Auvelity, VRAYLAR, NEUROSTAR TMS THERAPY SYSTEM, SPRAVATO.
Industry payments across OR — which companies pay providers there.
